Germline testing is a genetic screening that looks for inherited gene mutations found in every cell.  It can identify ...

A clustered family history of breast, ovarian, and colon cancers appropriately triggered germline testing, with BRCA1 mutation status informing individualized risk stratification and counseling.

SINGAPORE, March 5 — From December, Singaporeans identified as high risk for hereditary breast and ovarian cancer (HBOC) will be able to access subsidised genetic testing, the Ministry of Health (MOH) ...

Eligible patients can receive up to 70 per cent in subsidies for genetic tests, while MediShield Life coverage will be extended to selected risk-reducing surgical procedures.

The Alliance for Clinical Trials in Oncology has launched a national study aimed at improving how patients diagnosed with colorectal cancer communicate news of possible genetic risks to their ...

Rare diseases (RD) are more common than you might think. For every 20 people you know, one is likely affected by a rare disease. Of the 7,000 known RD conditions, 80% have a genetic origin, yet over ...

Indications for and implications of germline genetic testing (GGT) in patients with prostate cancer have expanded over the past decade, particularly related to precision therapies and management. GGT ...

Cancer is a disease that profoundly impacts lives, often leaving individuals and families with uncertainty and fear. However, advancements in medical science now enable us to take proactive steps in ...

Myriad Genetics partners with broadcaster Hannah Storm to promote breast cancer risk assessment and the importance of family health history. Myriad Genetics, Inc. has announced a collaboration with ...

MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S.